ライフサイエンスコーパス: propylene glycol

1 phoresis-induced spreading of stripes of 1,2 propylene glycol.

2 amolecular isotope ratios in four samples of propylene glycol.

3 and end-group deprotection to form hexa-1,3-propylene glycol.

4 ination of polyethylene glycol 400 0.4 % and propylene glycol 0.3 % (PEG/PG) (n = 72).

5 ss and market potential, the bioproducts are propylene glycol, 1,3-propanediol, 3-hydroxypropionic ac

6 of four treatments: (1) vehicle control (90% propylene glycol + 10% lactated Ringer solution); (2) 20

7 f 1,25-dihydroyvitamin D(3) in 0.1 ml of 95% propylene glycol:5% ethanol vehicle or vehicle only.

8 ubstrates for NADH biosynthesis, and produce propylene glycol, a precursor of pyruvate derived from g

9 Propylene glycol accumulated significantly in patients r

10 Propylene glycol accumulated significantly in pediatric

11 ctives were a) to document the occurrence of propylene glycol accumulation associated with continuous

12 Propylene glycol accumulation was determined by comparin

13 However, the propylene glycol accumulation was not associated with si

14 Propylene glycol accumulation was observed in six of nin

15 significant laboratory abnormalities due to propylene glycol accumulation were not observed.

16 dose lorazepam infusion, and the presence of propylene glycol accumulation, as evidenced by a high an

17 Propylene glycol accumulation, as reflected by a hyperos

18 , serum propylene glycol concentrations, and propylene glycol accumulation; and c) to assess the rela

19 This study investigated the propylene glycol alginate (PGA)-induced coacervation of

20 amel matrix (AMEL) suspended in a vehicle of propylene glycol alginate (PGA).

21 ial properties that can be attributed to the propylene glycol alginate vehicle.

22 The electronic cigarette solvents propylene glycol and glycerol are known to produce toxic

23 he main components of e-cigarette e-liquids (propylene glycol and glycerol), while the role of flavor

24 lets of well-chosen miscible liquids such as propylene glycol and water deposited on clean glass are

25 model is tested with a non-amphiphilic CPE (propylene glycol) and both nonionic and ionic amphiphili

26 rocarbons, including acetylated sugars, poly(propylene glycol), and oligo(vinyl acetate), have been u

27 at for the small osmolytes, ethylene glycol, propylene glycol, and glycerol, Deltax(u) scales with th

28 f three cryoprotectants (dimethyl sulfoxide, propylene glycol, and methanol) demonstrated that methan

29 methanol, methylethyl ketone, methylsulfone, propylene glycol, and trimethylsilanol.

30 , ethanol, ethylene glycol, isopropanol, and propylene glycol are obtained with greater than 95% sele

31 tios using the volatile lactic acid analogue propylene glycol as a model compound, measured by on-lin

32 The vehicle of lorazepam, propylene glycol, can cause hyperlactatemia and elevated

33 he cumulative dose of lorazepam received and propylene glycol concentration at the end of therapy was

34 receiving continuous lorazepam infusion, and propylene glycol concentration correlated with the cumul

35 The propylene glycol concentration increased during the stud

36 umulative dose of lorazepam received and the propylene glycol concentration measured at the end of th

37 mol gap was the strongest predictor of serum propylene glycol concentrations (r =.804, p =.001).

38 ill adults with normal renal function, serum propylene glycol concentrations may be predicted by the

39 een duration of lorazepam infusion and serum propylene glycol concentrations was observed (p =.637).

40 high-dose lorazepam infusion rate and serum propylene glycol concentrations was observed (r =.557, p

41 Serum propylene glycol concentrations were drawn at 48 hrs int

42 e relationship between lorazepam dose, serum propylene glycol concentrations, and propylene glycol ac

43 onship between high-dose lorazepam and serum propylene glycol concentrations.

44 relationship between the osmol gap and serum propylene glycol concentrations.

45 aminant systems, glycerin/diethylene glycol, propylene glycol/diethylene glycol, and lactose/melamine

46 or 1,8-diazabicyclo [5,4,0] undec-7-ene, in propylene glycol:ethanol (7:3) to hairless mouse skin an

47 sing vehicle excipient, such as substituting propylene glycol for PEG400, provides an alternative app

48 Using propylene glycol, H-bonding and ionic interactions were

49 tability during lactic acid hydrogenation to propylene glycol in the presence of methionine.

50 chirmer test compared to polyethylene glycol/propylene glycol in the treatment of dry eye disease.

51 However, propylene glycol may also interfere with renal tubular f

52 Although a poly(ethylene/propylene glycol) (PEG/PPG) copolymer mixture is far too

53 -cigarettes heat and aerosolize the solvents propylene glycol (PG) and glycerol (GLY), thereby afford

54 Ethanol (EtOH), isopropyl alcohol (IPA), and propylene glycol (PG) increase topical drug delivery, bu

55 The influence of choice of flavour solvent, propylene glycol (PG) or triacetin (TA), was investigate

56 s in three different refill "e-liquids" were propylene glycol (PG), glycerin, nicotine, ethanol, acet

57 (EG), ethyl acetate (EA), isopropanol (IPA), propylene glycol (PG), polyethylene glycol-400 (PEG-400)

58 Deuterated water (D2O), propylene glycol (PG-d8), and dimethyl sulphoxide (DMSO-

59 SDS) and nonionic poly(ethylene glycol)-poly(propylene glycol)-poly(ethylene glycol) (PEO-PPO-PEO) tr

60 Using polymer interfaces modified with poly(propylene glycol) (PPG) chains, our results indicate tha

61 Administration of 1 mg E2 in propylene glycol produced a CPP.

62 Notably, 1 mg E2 in propylene glycol produced moderate levels of E2 in the n

63 tri-, tetra-, penta(ethylene glycol) and tri(propylene glycol) separating the 1,2,5,6-tetrahydropyrid

64 her orally or intracolonically in an aqueous propylene glycol solution and caused dramatic increases

65 e samples was performed, and the presence of propylene glycol, sorbic and benzoic acids was found in

66 d quantification of semi-volatile additives (propylene glycol, sorbic and benzoic acids) in wines.

67 ation ranges 0-250, 0-125, and 0-250mg/L for propylene glycol, sorbic and benzoic acids, respectively

68 a two-step reaction of diethyl fumarate and propylene glycol through a bis(hydroxypropyl) fumarate d

69 of dosing vehicle excipients such as PEG400, propylene glycol, Tween 80, and hydroxypropyl-beta-cyclo

70 olization of cyclosporin A (300 mg in 4.8 ml propylene glycol) using an AeroTech II jet nebulizer was

71 2, ovariectomized rats were SC administered propylene glycol vehicle (n = 11), 10 microg (n = 13), o

72 ), and mephedrone (4-methylmethcathinone) in propylene glycol vehicle using concentrations ranging fr

73 ere subcutaneously injected with 0.5 mg P or propylene glycol vehicle.

74 applied as a close-to-saturated solution in propylene glycol, was directly observed to crystallise i